We are proud to recognize this year’s outstanding early-career Chinese cancer researchers for their remarkable contributions to advancing cancer research and drug development.
Since 2010, the Asian Fund for Cancer Research and the US Chinese Anti-Cancer Association have jointly presented the USCACA-AFCR Young Investigator Award to support promising scientists working at the intersection of U.S.-China collaboration. These awardees have already demonstrated great potential in translating laboratory discoveries into innovative treatments that benefit patients around the world.
To learn more about the Award and its previous winners, please click here.
👏 Join us in congratulating the 2024 award recipients as they lead the way toward a future free of cancer!
